Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications
- PMID: 14755720
- DOI: 10.1002/ana.10846
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications
Abstract
Genomic triplication of the alpha-synuclein gene recently has been associated with familial Parkinson's disease in the Spellman-Muenter kindred. Here, we present an independent family, of Swedish-American descent, with hereditary early-onset parkinsonism with dementia due to alpha-synuclein triplication. Brain tissue available from affected individuals in both kindreds provided the opportunity to compare their clinical, pathological, and biochemical phenotypes. Of note, studies of brain mRNA and soluble protein levels demonstrate a doubling of alpha-synuclein expression, consistent with molecular genetic data. Pathologically, cornu ammonis 2/3 hippocampal neuronal loss appears to be a defining feature of this form of inherited parkinsonism. The profound implications of alpha-synuclein overexpression for idiopathic synucleinopathies are discussed.
Comment in
-
Alpha-synuclein in Parkinson's disease: light from two new angles.Ann Neurol. 2004 Feb;55(2):153-6. doi: 10.1002/ana.20036. Ann Neurol. 2004. PMID: 14755715 No abstract available.
Similar articles
-
Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease.Neurosci Lett. 2004 Aug 26;367(1):97-100. doi: 10.1016/j.neulet.2004.05.100. Neurosci Lett. 2004. PMID: 15308306
-
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.Ann Neurol. 2004 Feb;55(2):164-73. doi: 10.1002/ana.10795. Ann Neurol. 2004. PMID: 14755719
-
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication.Neurology. 2007 Mar 20;68(12):916-22. doi: 10.1212/01.wnl.0000254458.17630.c5. Epub 2007 Jan 24. Neurology. 2007. PMID: 17251522
-
Experimental models of Parkinson's disease.Nat Rev Neurosci. 2001 May;2(5):325-34. doi: 10.1038/35072550. Nat Rev Neurosci. 2001. PMID: 11331916 Review.
-
Gene dosage and pathogenesis of Parkinson's disease.Trends Mol Med. 2005 Mar;11(3):91-6. doi: 10.1016/j.molmed.2005.01.001. Trends Mol Med. 2005. PMID: 15760766 Review.
Cited by
-
SNCA Gene Polymorphism may Contribute to an Increased Risk of Alzheimer's Disease.J Clin Lab Anal. 2016 Nov;30(6):1092-1099. doi: 10.1002/jcla.21986. Epub 2016 May 17. J Clin Lab Anal. 2016. PMID: 27184464 Free PMC article.
-
Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy.Mol Cell Biochem. 2021 Jul;476(7):2739-2752. doi: 10.1007/s11010-021-04120-6. Epub 2021 Mar 9. Mol Cell Biochem. 2021. PMID: 33687588 Review.
-
N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells.J Alzheimers Dis. 2010;19(1):179-89. doi: 10.3233/JAD-2010-1226. J Alzheimers Dis. 2010. PMID: 20061637 Free PMC article.
-
Cognitive Impairment in Genetic Parkinson's Disease.Parkinsons Dis. 2021 Dec 30;2021:8610285. doi: 10.1155/2021/8610285. eCollection 2021. Parkinsons Dis. 2021. PMID: 35003622 Free PMC article. Review.
-
Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?Parkinsonism Relat Disord. 2014 Jun;20(6):584-9; discussion 584. doi: 10.1016/j.parkreldis.2014.02.021. Epub 2014 Mar 5. Parkinsonism Relat Disord. 2014. PMID: 24656894 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous